Skip to content

Probiotic Intervention for Acute Stress

Probiotic Intervention for Acute Stress

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03284905
Enrollment
70
Registered
2017-09-15
Start date
2017-10-02
Completion date
2018-04-04
Last updated
2019-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress

Brief summary

Efficacy of probiotics on acute stress

Interventions

DIETARY_SUPPLEMENTProbiotic supplement

Capsule containing freeze dried probiotic bacteria together with maize starch

DIETARY_SUPPLEMENTPlacebo supplement

Capsule containing maize starch

Sponsors

Probi AB
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* 19-35 years * SMBQ-score ≥3.75 * Understand Swedish in spoken and written terms * Willing and able to give written informed consent for participating in the study * Intake of probiotics within two weeks prior to the start of the study

Exclusion criteria

* BMI\> 30 * Pregnant * Antibiotic treatment in the last three months * Known disease (diabetes, pulmonary or cardiovascular disease, celiac disease, thyroid problems, gastrointestinal disease) or mental illness * Use of psychotropic drugs, beta blockers, asthma or rheumatoid arthritis drugs, steroid drugs or local steroid treatment

Design outcomes

Primary

MeasureTime frame
Reduction of the cortisol level during acute stress2.5 hours

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026